Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2019 of 6351
-
New transplant recipe may tame severe anemia
Disease control CompletedThe investigators retrospectively evaluted the safety and efficacy of the modified transplantation conditioning and aGVHD prophylaxis in severe aplastic anemia in 4 transplantation centers.
Sponsor: Hematology department of the 920th hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Liquid diet shows promise for Crohn's patients in new study
Disease control Recruiting nowThe goal of this observational study is to evaluate the effectiveness and safety of exclusive enteral nutrition (EEN) in adults with active Crohn's disease (CD), particularly in patients with complicated disease such as stricturing disease, enteric fistula, and intra-abdominal ab…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Brain zapping plus brain games shows promise for Alzheimer's
Symptom relief CompletedThis completed randomized trial evaluated the clinical and neural effects of high-definition transcranial direct current stimulation (HD-tDCS) combined with computerized cognitive training in patients with Alzheimer's disease. Participants were assigned to active HD-tDCS plus com…
Sponsor: Anhui Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New combo therapy aims to stop rare Cancer's return
Disease control Recruiting nowThis is an open-label, single center, one cohort, non-randomized, phase II study. The aim is to evaluate the efficacy and safety of the combination of hypofractionated radiotherapy (HRT) and pembrolizumab on local tumor control in mucosal melanoma patients. Treatment effect will …
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New antibody TST001 takes on stomach and pancreatic cancers
Disease control OngoingThis is an open label Phase I/IIa, First in Human trial of TST001, a recombinant humanized anti-Claudin 18.2 (CLDN18.2) IgG1 monoclonal antibody as monotherapy or in combination with nivolumab or standard of care. It is being tested against advanced and/or metastatic solid tumors…
Phase 1/2 • Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New cocktail of drugs shows promise for tough colorectal cancer
Disease control CompletedThis phase I trial studies the side effects and best dose of regorafenib when given together with ipilimumab and nivolumab in treating patients with microsatellite stable colorectal cancer that has spread to other places in the body (metastatic) and remains despite chemotherapy t…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a common asthma drug help treat a rare genetic disorder?
Disease control By invitation onlyPseudohypoparathyroidism is a genetic disorder with limited treatment options, characterized by early-onset obesity, short stature, hormone resistance and cognitive impairment. This phase 2 clinical trial will test the efficacy of theophylline, a phosphodiesterase inhibitor, in p…
Phase 2 • Sponsor: Jaclyn Tamaroff • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for brain cancer patients: drug may stop relapse
Disease control CompletedThe purpose of this additional part of the study is to test whether the study drug, nivolumab, is a safe treatment that will prevent participants' primary central nervous system lymphoma (PCNSL) from growing again (recurrence). Participants will be people with PCNSL who continue …
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can group family therapy help teens beat anorexia?
Symptom relief OngoingThe proposed project is an intensive multi family therapy (MFT) intervention involving patients with anorexia nervosa and their families. MFT interventions are informed from the principles of the family based treatment (FBT)/family therapy for Anorexia Nervosa (FT-AN) models. Thi…
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Genetic risk? new study aims to catch aggressive prostate cancer early
Knowledge-focused Recruiting nowThis study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive). Studying samples of blood, urine, and/or tissue in the laboratory may help doctors further understand the genetics of prostate …
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo shows promise for kids with transplant complication
Disease control CompletedThis open-label, single-arm, Phase II multi-center study enrolled 46 participants and investigated the activity, pharmacokinetics and safety of ruxolitinib added to the subject's immunosuppressive regimen among infants, children, and adolescents aged ≥28 days to \<18 years old wi…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New ablation strategy may improve heart rhythm control in persistent AFib
Disease control OngoingBrief summary: The objective of this study is to compare two different ablation strategies in participants with persistent atrial fibrillation and fibrotic areas in the left atrium. The participant will be randomized to pulmonary vein isolation or pulmonary vein isolation plus ab…
Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for frail lung cancer patients: Chemo-Free combo shows promise
Disease control CompletedThis is a randomized, open-label, multicenter, phase II trial investigating the combination of thoracic radiotherapy plus Durvalumab in patients with locally advanced, unresectable NSCLC (stage III) that are unfit for chemotherapy (e.g. due to age and/or frailty).
Phase 2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for lung cancer patients too weak for standard chemo?
Disease control Recruiting nowThe purpose of this study is to understand if treatment with one chemotherapy medication combined with immune therapy (pembrolizumab) is tolerable and effective for patients with lung cancer and performance status of 2 (PS2), which means you have limitations in carrying out certa…
Phase 1 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Mind-Controlled electrical stimulation helps stroke survivors walk again
Disease control CompletedThere are over 7 million stroke survivors in the US alone, with approximately 795,000 new cases annually. Despite the best available physiotherapy, 30-60% of stroke survivors remain affected by difficulty walking, with foot weakness often being the main cause. Given that post-str…
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Blood thinners may be unnecessary for minor lung clots, new trial suggests
Disease control Recruiting nowThe clinical significance of pulmonary embolism (PE) limited to the subsegmental pulmonary arteries, so called isolated subsegmental pulmonary embolism (SSPE), remains controversial. Whether isolated SSPE represents "true" PE, a clinically more benign form of PE, a physiologic lu…
Phase 4 • Sponsor: Drahomir Aujesky • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Gut bacteria may hold key to treating severe colitis
Knowledge-focused CompletedThis pilot prospective study will investigate the role of microbiota and known enteropathogens in Acute Severe Ulcerative Colitis (ASUC). Investigators will compare a group of patients hospitalized for an ASUC with patients experiencing a Non-Severe Ulcerative Colitis (NSUC) flar…
Early phase 1 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Tailored drug combo tested for tough head and neck cancers
Disease control CompletedIn this Phase II trial of personalized immunotherapy in R/M HNSCC, gene expression of LAG3 and CTLA4 by RNA seq will be determined to select the appropriate agent (Ipilimumab or Relatlimab) to add to Nivolumab in patients with recurrent and/or metastatic squamous cell carcinoma o…
Phase 2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Immunotherapy combo shows promise against stomach cancer in early trial
Disease control CompletedNeoadjuvant durvalumab (MEDI4736) plus docetaxel, oxaliplatin, S-1 (DOS) followed by surgery and adjuvant durvalumab plus S-1 chemotherapy in potentially resectable MMR proficient (pMMR) gastric or gastroesophageal junction (GEJ) adenocarcinoma
Phase 2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could taking drug breaks tame leukemia side effects?
Disease control OngoingThis phase II trial studies how well duvelisib on an intermittent (irregular) dosing schedule works in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell …
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC